Determinants of Muscle Strength in Chronic Kidney Disease
1 other identifier
interventional
110
1 country
3
Brief Summary
Aim of this study is to determine in chronic kidney disease patients:
- the involvement of malnutrition inflammation and atherogenesis syndrome (increase in C reactive protein and decrease in serum albumin) on voluntary muscle strength impairment
- the relationship between voluntary muscle strength and muscle mass
- the relationship between voluntary muscle strength and lean body mass
- the correlation between voluntary muscle strength and physical activity
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2016
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 4, 2016
CompletedFirst Submitted
Initial submission to the registry
June 6, 2016
CompletedFirst Posted
Study publicly available on registry
June 20, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 14, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2017
CompletedFebruary 28, 2019
January 1, 2017
1.4 years
June 6, 2016
February 26, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Voluntary muscle strength evaluated by handheld dynamometer
data will be measured in Newton.meter
1 day
Secondary Outcomes (5)
Muscle mass estimated by creatinine index evaluation
1 day
Lean body mass evaluated by electrical bioimpedance analysis
1 day
Physical activity estimated using the "Voorrips" score questionnaire
1 day
C reactive protein level
1 day
Albumin level
1 day
Study Arms (1)
Muscle strength
EXPERIMENTALsingle evaluation (the day of inclusion) of muscle strength (by handheld dynamometer), muscle mass (by creatinine index estimation), lean body mass (by electrical bioimpedance analysis), physical activity (by "Voorrips" score questionnaire), inflammatory and nutritional status.
Interventions
Evaluation of C reactive protein and albumin
Eligibility Criteria
You may qualify if:
- chronic kidney disease patient with extrarenal replacement therapy by hemodialysis for at least 3 months
- stable clinical condition (absence of infection, stroke or acute decompensation)
You may not qualify if:
- chronic kidney disease without extrarenal replacement therapy
- history of renal transplantation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
AIDER
Montpellier, 34295, France
GCS Help Lapeyronie, CHU Montpellier
Montpellier, 34295, France
AIDER
Nîmes, 30900, France
Related Publications (1)
Souweine JS, Kuster N, Chenine L, Rodriguez A, Patrier L, Morena M, Badia E, Chalabi L, Raynal N, Ohresser I, Leray-Moragues H, Mercier J, Hayot M, Le Quintrec M, Gouzi F, Cristol JP. Physical inactivity and protein energy wasting play independent roles in muscle weakness in maintenance haemodialysis patients. PLoS One. 2018 Aug 1;13(8):e0200061. doi: 10.1371/journal.pone.0200061. eCollection 2018.
PMID: 30067754DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jean-Paul CRISTOL, Prof
CHU Lapeyronie, Department of Biochemistry and Hormonology, Montpellier, FRANCE
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 6, 2016
First Posted
June 20, 2016
Study Start
January 4, 2016
Primary Completion
June 14, 2017
Study Completion
October 1, 2017
Last Updated
February 28, 2019
Record last verified: 2017-01
Data Sharing
- IPD Sharing
- Will not share